2022
DOI: 10.7759/cureus.27022
|View full text |Cite
|
Sign up to set email alerts
|

Neuroendocrine Carcinoma of the Gallbladder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
0
0
Order By: Relevance
“…GC has an extremely low incidence (less than 4%); however, its five-year survival rate does not exceed 5%[ 14 ]. Most patients have middle- or late-stage disease at the first visit; thus, their survival time does not exceed one year[ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…GC has an extremely low incidence (less than 4%); however, its five-year survival rate does not exceed 5%[ 14 ]. Most patients have middle- or late-stage disease at the first visit; thus, their survival time does not exceed one year[ 15 ].…”
Section: Discussionmentioning
confidence: 99%